Home Tags Biotech

Tag: Biotech

The think tank Helena and its partners hope to find treatments for diseases that lack them by creating new financial incentives.

Could treatments for Alzheimer’s disease and concussions be hanging out unused in your medicine cabinet? This think tank thinks so — and w...

The potential savings are "enormous," says Helena's Lyn Stoler. "And that's not even looking at the human health impact."
David Katzman, CEO of SmileDirectClub stands with founders Jordan Katzman and Alex Fenkell as the company debuts its IPO at the Nasdaq MarketSite in New York

Dispensed: A digital health IPO bust, Walmart’s push into healthcare, and an MIT project that didn’t live up to the hype

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Dan Chung is the clinical ophthalmic lead at Spark Therapeutics.

We got an inside look at how the biotech Spark used mazes to develop a first-of-its-kind treatment for eye disease on the way to selling itself for $4...

A team of scientists came up with a new way to measure how well a treatment for a rare form of blindness worked.
Proteus makes 'smart pills' embedded with sensors that tell your doctor when you've taken your medication. It announced a clinical trial in cancer on Thursday.

We got a look at the pitch deck of buzzy Silicon Valley health-tech startup Sempre Health. It reveals how a $4 billion industry is ripe for disruption...

Startup Sempre Health has raised $10.5 million to take aim at a well-known problem with people and their pills: they don't always take them.

Dispensed: Career advice from BI’s young healthcare leaders, a wild week for biotechs, and a list of white-hot AI startups

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can’t get to the kids who need it, and what a top health-te...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Biogen climbs as profits surge 72%, prompting the firm to boost 2019 guidance

The company is down about 35% over the last 12 months, with a failed Alzheimer's trial driving investors away in March.
The microbiome testing company uBiome has come under scrutiny after an FBI raid.

Dispensed: Oscar’s first moves in Medicare Advantage, uBiome’s new board members, and Novartis’ CEO’s commitment to wearing je...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Belgian biotech Galapagos surges after Gilead sinks another $5.1 billion into the firm

The deal gives Gilead rights outside Europe to the Belgian biotech company's drugs in development. Galapagos has six treatments in human testing.

Dispensed: Pharma’s next big megamerger, a string of healthcare IPOs, and why the CEO of Clover Health regrets setting up shop in Silicon Valley...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.